CMA takes DNA sequencing deal to Phase II
The UK’s Competition and Markets Authority has referred DNA analysis company Illumina’s acquisition of Pacific Biosciences for an in-depth review.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.